Enanta Pharmaceuticals (ENTA) EV to EBITDA (2013 - 2020)
Enanta Pharmaceuticals' (ENTA) EV to EBITDA came in at 45.52 for fiscal Q2 2020 (quarter ended Mar 31, 2020), up 160.8% from 17.45 a year earlier and up 35.1% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) EV to EBITDA (2013 - 2020) Analysis & Trends
For the trailing twelve months through Mar 31, 2020, EV to EBITDA at Enanta Pharmaceuticals was -28.80; for FY2019 (ended Sep 30, 2019), it came in at 21.22, up 42.9% from FY2018.
- In prior fiscal years, Enanta Pharmaceuticals' EV to EBITDA was 14.85 in FY2018 (-40.8%), 25.09 in FY2017 (+175.1%), 9.12 in FY2016 (+114.2%) and 4.26 in FY2015 (-87.2%).
- The fiscal Q2 2020 figure stands as the highest quarterly EV to EBITDA in data going back to fiscal Q2 2013.
- On a year-over-year basis, EV to EBITDA has increased in each of the last five quarters, with growth averaging 51.8% over the last seven quarters.
- The strongest year-over-year quarter for EV to EBITDA in the past five years was fiscal Q1 2020, with growth of 241.2%; the weakest was fiscal Q4 2015, with a decline of 87.2%.
- According to Business Quant data, EV to EBITDA for the three prior fiscal quarters was 33.69 (Q1 2020), 21.22 (Q4 2019) and 18.76 (Q3 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 45.52 |
| Dec 31, 2019 | 33.69 |
| Sep 30, 2019 | 21.22 |
| Jun 30, 2019 | 18.76 |
| Mar 31, 2019 | 17.45 |
| Dec 31, 2018 | 9.87 |
| Sep 30, 2018 | 14.85 |
| Jun 30, 2018 | 17.82 |
| Mar 31, 2018 | 17.42 |
| Dec 31, 2017 | 18.71 |
| Sep 30, 2017 | 25.09 |
| Sep 30, 2016 | 9.12 |
| Jun 30, 2016 | 5.16 |
| Mar 31, 2016 | 8.10 |
| Dec 31, 2015 | 4.88 |
| Sep 30, 2015 | 4.26 |
| Jun 30, 2015 | 5.94 |
| Mar 31, 2015 | 2.73 |
| Dec 31, 2014 | 8.86 |
| Sep 30, 2014 | 33.37 |
API Access
Enanta Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();